Cargando…
A review of soft-tissue sarcomas: translation of biological advances into treatment measures
Soft-tissue sarcomas are rare malignant tumors arising from connective tissues and have an overall incidence of about five per 100,000 per year. While this diverse family of malignancies comprises over 100 histological subtypes and many molecular aberrations are prevalent within specific sarcomas, v...
Autores principales: | Hoang, Ngoc T, Acevedo, Luis A, Mann, Michael J, Tolani, Bhairavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955018/ https://www.ncbi.nlm.nih.gov/pubmed/29785138 http://dx.doi.org/10.2147/CMAR.S159641 |
Ejemplares similares
-
Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications
por: Tolani, Bhairavi, et al.
Publicado: (2018) -
Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog
por: Tolani, Bhairavi, et al.
Publicado: (2018) -
Advances in the treatment of soft tissue sarcoma: focus on eribulin
por: Koliou, Panagiotis, et al.
Publicado: (2018) -
Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019) -
Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced
Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and
Bone Sarcoma Group
por: Nielsen, Ole S., et al.
Publicado: (2000)